SIMPLEX TRADING, LLC - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is and the CUSIP is 10501E901. A total of 3 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$1
-99.3%
9,100
-86.2%
0.00%
Q2 2023$135
+19.5%
65,800
+90.7%
0.00%
Q1 2023$113
+2.7%
34,500
-49.0%
0.00%
Q4 2022$110
-100.0%
67,600
-9.1%
0.00%
Q3 2022$328,000
+36.7%
74,400
-14.7%
0.00%
Q2 2022$240,000
+42.9%
87,200
+74.1%
0.00%
Q1 2022$168,000
-72.4%
50,100
-67.1%
0.00%
-100.0%
Q4 2021$608,000
-5.1%
152,100
-10.2%
0.00%0.0%
Q3 2021$641,000
-0.3%
169,3000.0%0.00%0.0%
Q2 2021$643,000
-9.2%
169,300
+9046.4%
0.00%0.0%
Q1 2021$708,000
-39.2%
1,851
-28.1%
0.00%
-50.0%
Q4 2020$1,165,000
-43.0%
2,576
+113.2%
0.00%
-33.3%
Q3 2020$2,043,000
+173.1%
1,208
+80.8%
0.00%
+200.0%
Q2 2020$748,000
-6.3%
668
-61.2%
0.00%0.0%
Q1 2020$798,000
+8766.7%
1,721
+7382.6%
0.00%
Q4 2019$9,000
-67.9%
23
-68.9%
0.00%
Q3 2019$28,000
+1300.0%
74
+957.1%
0.00%
Q2 2019$2,000
-77.8%
7
-68.2%
0.00%
Q1 2019$9,000
+28.6%
22
+10.0%
0.00%
Q4 2018$7,00020
+5.3%
0.00%
Q4 2017$019
-54.8%
0.00%
Q3 2017$0
-100.0%
42
-80.6%
0.00%
Q2 2017$3,0000.0%217
+19.2%
0.00%
Q1 2017$3,000182
+1720.0%
0.00%
Q1 2015$0100.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 56,200$185,4600.00%
SIMPLEX TRADING, LLC 34,500$1130.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders